September is World Alzheimer’s month.

Let’s spread awareness together!

Alzheimer’s Disease (AD) is the most wide-spread form of dementia affecting dozens of millions patients worldwide. This is a condition which impacts both the quality of life of the suffering individual and their friends and family. While no cure is currently available, there is a growing number of facilities and treatment options to mitigate the disease and to offer the much-needed support to families. Clinical trials are also ongoing worldwide in search for the cure for Alzheimer’s Disease.  

GCT focuses on CNS and Neurology trials and has been running trials in Alzheimer’s Disease since 2001. We are closely familiar with Key Opinion Leaders (KOLs) and the best clinical sites worldwide. Reach out to GCT at bd@gctrials.com for more information.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.


GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login



© 2001—2021 Global Clinical Trials, LLC

All rights reserved.